Upstate Active Clinical Trials
Study Title:A Phase III Randomized Trial of Adding Vincristine-topotecan-cyclophosphamide to Standard Chermotherapy in Initial Treatment of non-metastatic Ewing Sarcoma
What is the purpose of the study?Randomized treatment study to look at combination chemotherapy in treating patients with non-metastatic extracranial Ewing sarcoma.
Upstate Institutional Review Board (IRB) Number:253867
Patient Age Group:Children
Principal Investigator:Karol H Kerr, MD
Who can I contact for more information?
Name: Beatriz Kovar